CCL20 displays antimicrobial activity against cryptosporidium parvum, but its expression is reduced during infection in the intestine of neonatal mice

Journal of Infectious Diseases

Volumn 212, Issue 8, 2015, Pages 1332-1340

  Guesdon, William ^a,b   Auray, Gaël ^a,b   Pezier, Tiffany ^a,b   Bussière, Françoise I ^a,b   Drouet, Françoise ^a,b   Le Vern, Yves ^a,b,c   Marquis, Mathilde ^a,b   Potiron, Laurent ^a,b   Rabot, Sylvie ^d   Bruneau, Aurelia ^d   Werts, Catherine ^e   Laurent, Fabrice ^a,b   Lacroix Lamandé, Sonia ^a,b  

^a UR1282   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c CEMAGREF   (France)

^d UMR1319 MICALIS   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

antimicrobial activity; CCL20; chemokine; Cryptosporidium parvum; neonatal mice

Indexed keywords

GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MYELOID DIFFERENTIATION FACTOR 88; ANTIINFECTIVE AGENT; CCL20 PROTEIN, MOUSE; MICRORNA; MIRN21 MICRORNA, MOUSE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; DRUG RESPONSE; ILEUM; IMMUNOCOMPETENT CELL; INTESTINE FLORA; INTESTINE INFECTION; MOUSE; NEWBORN; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL LINE; DISEASE MODEL; EPITHELIUM CELL; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; INTESTINE; METABOLISM; PARASITOLOGY; PHYSIOLOGY; SPOROZOITE;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFECTIVE AGENTS; CELL LINE; CHEMOKINE CCL20; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; INTERFERON-GAMMA; INTESTINES; MICE; MICE, INBRED C57BL; MICRORNAS; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPOROZOITES;

EID: 84943410569     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv206     Document Type: Article

References (41)

1. Zhao L, Xia J, Wang X, Xu F. Transcriptional regulation of CCL20 expression. Microbes Infect. 2014; 16: 864-70
2. Lee AY, Eri R, Lyons AB, Grimm MC, Korner H. CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil? Front Immunol. 2013; 4: 194
3. Regan T, Nally K, Carmody R, et al. Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J Immunol. 2013; 191: 6084-92
4. Sugiura Y, Kamdar K, Khakpour S, Young G, Karpus WJ, DePaolo RW. TLR1-induced chemokine production is critical for mucosal immunity against Yersinia enterocolitica. Mucosal Immunol. 2013; 6: 1101-9
5. Fujiie S, Hieshima K, Izawa D, et al. Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB [correction of NK-kappaB]. Int Immunol. 2001; 13: 1255-63
6. Sierro F, Dubois B, Coste A, Kaiserlian D, Kraehenbuhl JP, Sirard JC. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci U S A. 2001; 98: 13722-7
7. Hoover DM, Boulegue C, Yang D, et al. The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human betadefensins. J Biol Chem. 2002; 277: 37647-54
8. Striepen B. Time to tackle cryptosporidiosis. Nature. 2013; 503: 189-91
9. Ojcius DM, Perfettini JL, Bonnin A, Laurent F. Caspase-dependent apoptosis during infection with Cryptosporidium parvum. Microbes Infect. 1999; 1: 1163-8
10. McCole DF, Eckmann L, Laurent F, Kagnoff MF. Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect Immun. 2000; 68: 1710-3
11. Lacroix-Lamande S, Mancassola R, Naciri M, Laurent F. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection. Infect Immun. 2002; 70: 2090-9
12. Auray G, Lacroix-Lamande S, Mancassola R, Dimier-Poisson I, Laurent F. Involvement of intestinal epithelial cells in dendritic cell recruitment during C. parvum infection. Microbes Infect. 2007; 9: 574-82
13. Laurent F, Eckmann L, Savidge TC, et al. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect Immun. 1997; 65: 5067-73
14. Lantier L, Lacroix-Lamande S, Potiron L, et al. Intestinal CD103+ dendritic cells are key players in the innate immune control of Cryptosporidium parvum infection in neonatal mice. PLoS Pathog. 2013; 9: e1003801
15. Giacometti A, Cirioni O, Del Prete MS, et al. In vitro effect on Cryptosporidium parvum of short-Term exposure to cathelicidin peptides. J Antimicrob Chemother. 2003; 51: 843-7
16. Carryn S, Schaefer DA, Imboden M, Homan EJ, Bremel RD, RiggsMW. Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms. J Parasitol. 2012; 98: 199-204
17. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V. Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun. 2004; 72: 2772-9
18. Lacroix S, Mancassola R, Naciri M, Laurent F. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection. Infect Immun. 2001; 69: 1635-42
19. Bens M, Bogdanova A, Cluzeaud F, et al. Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. Am J Physiol. 1996; 270: C1666-74
20. Perreault N, Beaulieu JF. Primary cultures of fully differentiated and pure human intestinal epithelial cells. Exp Cell Res. 1998; 245: 34-42
21. Barrier M, Lacroix-Lamande S, Mancassola R, et al. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice. J Infect Dis. 2006; 193: 1400-7
22. Sonnier DI, Bailey SR, Schuster RM, Gangidine MM, Lentsch AB, Pritts TA. Proinflammatory chemokines in the intestinal lumen contribute to intestinal dysfunction during endotoxemia. Shock. 2012; 37: 63-9
23. Yang D, Chen Q, Hoover DM, et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol. 2003; 74: 448-55
24. Vongsa RA, Zimmerman NP, Dwinell MB. CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- And CCL20-mediated restitution of colonic epithelial cells. J Biol Chem. 2009; 284: 10034-45
25. Yung SC, Murphy PM. Antimicrobial chemokines. Front Immunol. 2012; 3: 276
26. Soboll G, Crane-Godreau MA, Lyimo MA, Wira CR. Effect of oestradiol on PAMP-mediated CCL20/MIP-3 alpha production by mouse uterine epithelial cells in culture. Immunology. 2006; 118: 185-94
27. Sibartie S, OHara AM, Ryan J, et al. Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria. BMC Immunol. 2009; 10: 54
28. Theodos CM, Sullivan KL, Griffiths JK, Tzipori S. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection. Infect Immun. 1997; 65: 4761-9
29. Zhou R, Feng Y, Chen XM. Non-coding RNAs in epithelial immunity to Cryptosporidium infection. Parasitology. 2014; 141: 1233-43
30. Vicinus B, Rubie C, Faust SK, et al. miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells. Cancer Lett. 2012; 316: 105-12
31. Vicinus B, Rubie C, Stegmaier N, et al. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation. Oncol Rep. 2013; 30: 1285-92
32. Sperandio B, Regnault B, Guo J, et al. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med. 2008; 205: 1121-32
33. Pollok RC, Farthing MJ, Bajaj-Elliott M, Sanderson IR, McDonald V. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology. 2001; 120: 99-107
34. Castellanos-Gonzalez A, Yancey LS, Wang HC, et al. Cryptosporidium infection of human intestinal epithelial cells increases expression of osteoprotegerin: a novel mechanism for evasion of host defenses. J Infect Dis. 2008; 197: 916-23
35. Hu G, Zhou R, Liu J, et al. MicroRNA-98 and let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-containing protein in response to microbial challenge. J Immunol. 2009; 183: 1617-24
36. Chen XM, Splinter PL, OHara SP, LaRusso NF A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem. 2007; 282: 28929-38
37. Sobirk SK, Morgelin M, Egesten A, Bates P, Shannon O, Collin M. Human chemokines as antimicrobial peptides with direct parasiticidal effect on Leishmania mexicana in vitro. PLoS One. 2013; 8: e58129
38. Imboden M, Riggs MW, Schaefer DA, Homan EJ, Bremel RD. Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice. Antimicrob Agents Chemother. 2010; 54: 1385-92
39. Imboden M, Schaefer DA, Bremel RD, Homan EJ, RiggsMW. Antibody fusions reduce onset of experimental Cryptosporidium parvum infection in calves. Vet Parasitol. 2012; 188: 41-7
40. Lantier L, Drouet F, Guesdon W, et al. Poly(I: C)-induced protection of neonatal mice against intestinal Cryptosporidium parvum infection requires an additional TLR5 signal provided by the gut flora. J Infect Dis. 2014; 209: 457-67
41. Lacroix-Lamande S, Guesdon W, Drouet F, Potiron L, Lantier L, Laurent F. The gut flora is required for the control of intestinal infection by poly(I: C) administration in neonates. Gut Microbes. 2014; 5: 533-40